Introduction
Background
Eczema, or atopic dermatitis, is a common inflammatory disease of the skin. The condition often has its start in childhood and follows a variable and sometimes unremitting course. Historically, this disease has been considered a part of a triad of "atopy" that included asthma and allergic rhinitis, though this association has recently come into question. Although not a cause of significant mortality, the visible and chronic nature of eczema can be a source of emotional stress.
Pathophysiology
The precise mechanism for the development of eczema is unknown. Whether the clinical manifestations of atopic dermatitis (AD) are the result of violation of the epidermis and the subsequent contact between environmental irritants and immune cells, or the reverse sequence, is debatable. Nonetheless, the epidermis is the first line of defense between the body and the environment and, when intact, shields the body from a variety of irritants, allergens, and microbes. This barrier, which is maintained by differentiated keratinocytes and structural proteins, can be compromised by inheritance, trauma, decreased humidity, change in pH, and infection.
Atopic skin additionally has diminished ability to maintain water; this dry skin leads to scratching, which further contributes to the release of proinflammatory mediators. Eczema is a biphasic T-cell – mediated disease: TH2 is more prevalent in the acute phase, and TH1 predominates in the chronically affected skin.1 Patients with atopic dermatitis have elevated serum IgE levels, peripheral eosinophilia, and overall greater numbers of immune mediators and cytokines.
Frequency
Atopic dermatitis is the most common inflammatory skin disease in children, affecting up to 17% of the pediatric population in the United States, with increasing prevalence over the past several decades.
United States
Prevalence of atopic dermatitis ranges from approximately 7-17% in children.2 A small percentage of affected children will have the disease into adulthood.
International
Studies in Japan and Northern Europe have found similar prevalence, with industrialized and westernized nations noting increasing trends of patients with atopic dermatitis.
Mortality/Morbidity
Mortality is not associated with atopic dermatitis. The impact of eczema is hard to measure but has real personal, social, and financial consequences. The burden includes but is not limited to professional fees, hospitalization, pain/suffering, social isolation, poor self-esteem, and work and/or school performance or absence. Additionally, patients suffering from atopic dermatitis are prone to bacterial superinfection.
Sex
Data shows a slightly increased prevalence of atopic dermatitis in female children.
Age
Atopic dermatitis predominantly affects infants and young children. Eczema is apparent in the first year of life in 60% of cases, and its onset is before 5 years in 75% of cases.3 Onset of eczematous appearing disease in adulthood should lead the physician to consider another diagnosis.
A triphasic course of atopic dermatitis across the lifespan has been proposed. Phase I develops before IgE sensitization has taken place and occurs mostly in infants who are likely genetically predisposed to the disease. Phase II involves IgE sensitization to food, environmental antigens, or both. Phase III is the product of chronic scratching and is characterized by the formation of IgE autoantibodies against proteins of keratinocytes and endothelial cells.
Clinical
History
The hallmarks of atopic dermatitis are intense pruritus, chronic eczematous skin lesions, and epidermal thickening and hypertrophy.
- The emergency physician often is the first to diagnose atopic dermatitis. The most common presentation is that of infants, usually younger than 6 months, brought in by their parents for a persistent rash. Before coming to the ED, the parents may have tried a number of over-the-counter and home remedies. Parents usually report that the rash has waxed and waned for months with a history of dry skin since birth.
- Clinicians should inquire about a family history of asthma, hay fever, allergy, and other atopic diseases. Patients with pertinent medical or family history of such disease tend to have a worse prognosis.
- Parents may also give a history of poor sleep or increased irritability in the patients, which is due to the desire to scratch the skin during sleep. Atopic dermatitis begins with intense pruritus, leading the patient to scratch, which results in the characteristic rash.
- Atopic dermatitis typically is not associated with fever or other constitutional symptoms, and the presence of these should prompt the clinician to look for bacterial superinfection.
Physical
Atopic dermatitis is a spectrum of disease that varies in presentation, severity, and distribution. Eczema defies a simple definition as the disease has differing characteristics depending on the age of the patient and the stage of the disease course.
- Lesions may be acute, subacute, or chronic, each with a characteristic appearance. Lesions from one stage can convert into another stage at any time due to processes such as manipulation, irritation, allergy, or infection.
- Acute lesions are intensely itchy and present as vesicles and blisters with intense redness.
- Subacute disease is characterized by slight-to-moderate itching, pain, stinging, burning and redness, scaling, and fissuring of the skin with a parched and scalded appearance.
- Chronic eczematous inflammation demonstrates thickened skin, accentuated skin lines, excoriations, and fissuring accompanying a moderate-to-intense itch.
- The pattern of skin manifestations also differs across the lifespan.
- In infantile atopic dermatitis, pruritic, red, scaly, and crusted lesions are typically found on the extensor surfaces and cheeks or scalp, with severe cases possibly presenting with vesicles, serous exudates, or crusting. The diaper area is protected and usually spared.
- The lesions in the childhood stage have less exudation; the skin often demonstrates lichenified plaques in a flexural distribution, commonly antecubital and popliteal fossae, volar aspect of the wrists, ankles, and neck.
- Adult eczema has a similar distribution to that in childhood atopic dermatitis but is increasingly localized and lichenified with thickened skin, increased skin markings, and excoriated and fibrotic papules.
- Certain characteristic patterns are worth mentioning.
- Eczema that appears as one or several coin-shaped plaques is called nummular eczema.
- Plaques with prominent skin lines are referred to as lichen simplex chronicus. These lesions are characterized by intense pruritus that ceases when pain replaces itch.
Diagnosis of atopic dermatitis is made by observing representative clinical features of the disease. The Hanifin and Rajka diagnostic criteria, which consist of 4 major and 23 minor criteria has traditionally been used, but it is time consuming and not manageable. The UK working group on atopic dermatitis has the following criteria for diagnosis, which has been most extensively validated in clinical trials.4 Evidence of itchy skin with 3 more of the following:
- History of skin crease involvement
- Presence of generally dry skin within in the past year
- Symptoms in a child beginning before the age of 2 years
- Visible involvement of dermatitis involving flexural surfaces
The complete Hanifin and Rajka criteria are included below:
- Major criteria (need 3 or more)
- Pruritus
- Typical morphology and distribution
- Flexural lichenification in adults
- Facial and extensor involvement in infants and children
- Dermatitis - Chronically or chronically relapsing
- Personal or family history of atopy (asthma, allergic rhinitis, atopic dermatitis)
- Minor criteria (need 3 or more)
- Cataracts
- Cheilitis
- Conjunctivitis - Recurrent
- Eczema - Perifollicular accentuation
- Facial pallor or erythema
- Food intolerance
- Hand dermatitis - Nonallergic
- Ichthyosis
- IgE - Elevated
- Immediate (type I) skin test reactivity
- Infections (cutaneous)
- Dennie-Morgan infraorbital fold
- Itching when sweating
- Keratoconus
- Keratosis pilaris
- Nipple dermatitis
- Orbital darkening
- Palmar hyperlinearity
- Pityriasis alba
- White dermographism
- Wool intolerance
- Xerosis
Causes
Atopic dermatitis is a complex genetic disease that results from an array of gene-gene and gene-environment interactions. Most experts believe that atopic dermatitis has a genetic basis. This is supported by twin studies and chromosome studies that suggest the trait might be inherited via a maternal gene located on chromosome 11. Clinical studies have also shown a higher risk of atopy in children with maternal atopy than in children with paternal atopy.5
Two theories have been proposed to explain the manifestations of atopic dermatitis. Atopic dermatitis was traditionally thought to be caused by an innate immunologic disturbance leading to IgE sensitization, which later results in disruption of the epithelial barrier, though this supposed mechanism is falling out of favor. Alternatively, it is thought that skin breakdown precedes the inflammatory process and an intrinsic epithelial cell defect leads to barrier disruption of the skin and that immunologic imbalance is an "epiphenomenon".1 Genetic defects in filaggrin, a group of structural proteins, have been cited as a major cause of atopic dermatitis.6,7 The upregulation of a protease stratum corneum chymotryptic enzyme is also being investigated in the cause of atopic dermatitis.
Chronic eczema is a disease that is somewhat behaviorally mediated. Skin thickening and plaque formation is dependent on habitual scratching.
More on Dermatitis, Atopic |
Overview: Dermatitis, Atopic |
| Differential Diagnoses & Workup: Dermatitis, Atopic |
| Treatment & Medication: Dermatitis, Atopic |
| Follow-up: Dermatitis, Atopic |
| Multimedia: Dermatitis, Atopic |
| References |
| Next Page » |
References
Wu Chang M. Journal Watch, Review of Atopic Dermatitis. Apr 2 2008;[Full Text].
Laughter D, Istvan JA, Tofte SJ, Hanifin JM. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol. Oct 2000;43(4):649-55. [Medline].
Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol. Jan 1994;30(1):35-9. [Medline].
Brenninkmeijer EE, Schram ME, Leeflang MM, Bos JD, Spuls PI. Diagnostic criteria for atopic dermatitis: a systematic review. Br J Dermatol. Apr 2008;158(4):754-65. [Medline].
Ruiz RG, Kemeny DM, Price JF. Higher risk of infantile atopic dermatitis from maternal atopy than from paternal atopy. Clin Exp Allergy. Aug 1992;22(8):762-6. [Medline].
Sandilands A, Smith FJ, Irvine AD, McLean WH. Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol. Jun 2007;127(6):1282-4. [Medline].
McGrath JA, Uitto J. The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol Med. Jan 2008;14(1):20-7. [Medline].
[Guideline] Leung DY, Nicklas RA, Li JT, Bernstein IL, et al. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol. Sep 2004;93(3 Suppl 2):S1-21. [Medline]. [Full Text].
Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol. Dec 1999;135(12):1522-5. [Medline].
Betsi GI, Papadavid E, Falagas ME. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol. 2008;9(2):93-103. [Medline].
Michail SK, Stolfi A, Johnson T, Onady GM. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy Asthma Immunol. Nov 2008;101(5):508-16. [Medline].
Yang YW, Tsai CL, Lu CY. Exclusive breastfeeding and incident atopic dermatitis in childhood: a systematic review and meta-analysis of prospective cohort studies. Br J Dermatol. Feb 23 2009;[Medline].
Ben-Gashir MA, Seed PT, Hay RJ. Predictors of atopic dermatitis severity over time. J Am Acad Dermatol. Mar 2004;50(3):349-56. [Medline].
Boehme SA, Franz-Bacon K, Chen EP, Sasik R, Sprague LJ, Ly TW, et al. A small molecule CRTH2 antagonist inhibits FITC-induced allergic cutaneous inflammation. Int Immunol. Jan 2009;21(1):81-93. [Medline].
Chan LS. Atopic dermatitis in 2008. Curr Dir Autoimmun. 2008;10:76-118. [Medline].
Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol. Jul 2006;118(1):3-21; quiz 22-3. [Medline].
Eichenfield LF, Hanifin JM, Luger TA, Stevens SR, Pride HB. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. Dec 2003;49(6):1088-95. [Medline].
Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the 'hygiene hypothesis': too clean to be true?. Br J Dermatol. Feb 2005;152(2):202-16. [Medline].
Grimalt R, Mengeaud V, Cambazard F,. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology. 2007;214(1):61-7. [Medline].
Gupta J, Grube E, Ericksen MB, Stevenson MD, Lucky AW, Sheth AP. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. J Allergy Clin Immunol. Mar 2008;121(3):725-730.e2. [Medline].
Habif. Clinical Dermatology. 4th ed. Mosby Inc; 2004.
Habif TP. Clinical Dermatology: Fourth Edition, A Color Guide to Diagnosis and Therapy. 2004:105-128.
Hanifin JM, Paller AS, Eichenfield L, et al. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J Am Acad Dermatol. Aug 2005;53(2 Suppl 2):S186-94. [Medline].
Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess. 2000;4(37):1-191. [Medline].
Kang K, Polster AM, Nedorost ST, et al. Atopic dermatitis. In: Bolognia JL, Jorizzo JL, Rapini RP, et al, eds. Dermatology. New York: Mosby; 2003:199.
Lane JE, Cheyney JM, Lane TN, Kent DE, Cohen DJ. Treatment of recalcitrant atopic dermatitis with omalizumab. J Am Acad Dermatol. Jan 2006;54(1):68-72. [Medline].
Larsen FS, Holm NV, Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol. Sep 1986;15(3):487-94. [Medline].
Loden M. The skin barrier and use of moisturizers in atopic dermatitis. Clin Dermatol. Mar-Apr 2003;21(2):145-57. [Medline].
Mancini AJ, Kaulback K, Chamlin SL. The socioeconomic impact of atopic dermatitis in the United States: a systematic review. Pediatr Dermatol. Jan-Feb 2008;25(1):1-6. [Medline].
Rhodes AR. Treatment of atopic dermatitis: old and new modalities. Clin Rev Allergy. Feb 1986;4(1):87-99. [Medline].
Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet. Jun 6 1998;351(9117):1715-21. [Medline].
Sauer GC. Manual of Skin Diseases. Publishers: Lippincott Williams & Wilkins; 1991:77-84.
Simpson EL, Hanifin JM. Atopic dermatitis. Med Clin North Am. Jan 2006;90(1):149-67, ix. [Medline].
Trepka MJ, Heinrich J, Wichmann HE. The epidemiology of atopic diseases in Germany: an east-west comparison. Rev Environ Health. Jul-Sep 1996;11(3):119-31. [Medline].
Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. Jan 1999;103(1 Pt 1):125-38. [Medline].
Further Reading
Keywords
dermatitis, atopic dermatitis, atopy, atopic disease, dry skin, eczema, allergy, dermatitis treatment, dermatitis causes, dermatitis symptoms, ichthyosis vulgaris, keratosis pilaris, hand and foot dermatitis, keratoconus, chronic pruritic skin condition, fishlike scales, horny follicular papules, fissuring of the palms, fissuring of the soles, facial erythema, pityriasis alba, increased palmar linear markings, infraorbital fold, Dennie-Morgan line, pilaris, perioral pallor




Overview: Dermatitis, Atopic